• ©2016 Cardea Associates, Inc.
  • ©2016 Cardea Associates, Inc.
  • ©2016 Cardea Associates, Inc.

Introducing CardeaScreen

The new ECG device in-tune with the young athlete's heart.

Sudden cardiac arrest (SCA) is the leading medical cause of death in sport participants and often is the first symptom of a cardiac condition.  Current research shows that the traditional Pre-Participation Exam (PPE), consisting of a physical exam and review of the family history, has low sensitivity and high cost, relative to the ECG, in detecting cardiac abnormalities.

CardeaScreen is a new portable, hand-held ECG device developed for screening young athletes’ hearts. Its custom algorithms can help physicians quickly and accurately identify abnormal cardiac conditions that may lead to SCA, or other quality of life limiting conditions, through high-quality ECGs and easy-to-use tools for over-reading and reporting.

CardeaScreen provides medical professionals with the diagnostic data that they need to help save lives.